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Background: Although oral cavity, pharyngeal, oesophageal and gastric cancers share some risk factors, no
comparative analysis of mortality rate trends in these illnesses has been undertaken in Spain. This study aimed to
evaluate the independent effects of age, death period and birth cohort on the mortality rates of these tumours.
Methods: Specific and age-adjusted mortality rates by tumour and sex were analysed. Age-period-cohort log-linear
models were fitted separately for each tumour and sex, and segmented regression models were used to detect
changes in period- and cohort-effect curvatures.
Results: Among men, the period-effect curvatures for oral cavity/pharyngeal and oesophageal cancers displayed a
mortality trend that rose until 1995 and then declined. Among women, oral cavity/pharyngeal cancer mortality
increased throughout the study period whereas oesophageal cancer mortality decreased after 1970. Stomach cancer
mortality decreased in both sexes from 1965 onwards. Lastly, the cohort-effect curvature showed a certain degree of
similarity for all three tumours in both sexes, which was greater among oral cavity, pharyngeal and oesophageal
cancers, with a change point in evidence, after which risk of death increased in cohorts born from the 1910-1920s
onwards and decreased among the 1950–1960 cohorts and successive generations. This latter feature was likewise
observed for stomach cancer.
Conclusions: While the similarities of the cohort effects in oral cavity/pharyngeal, oesophageal and gastric tumours
support the implication of shared risk factors, the more marked changes in cohort-effect curvature for oral cavity/
pharyngeal and oesophageal cancer could be due to the greater influence of some risk factors in their aetiology,
such as smoking and alcohol consumption. The increase in oral cavity/pharyngeal cancer mortality in women
deserves further study.
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Change-points, Time trends, SpainBackground
Cancers of the upper gastrointestinal (GI) tract are rela-
tively frequent. The upper gastrointestinal tract usually
refers to the oral cavity and pharynx, oesophagus and
stomach (though some classifications also include the
duodenum). In 2008, gastric cancer was estimated to be* Correspondence: naragones@isciii.es
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article, unless otherwise stated.the fourth most common cancer worldwide and the
second leading cause of death in both sexes [1]. Taken
together, oral cavity and pharyngeal cancers ranked
eighth in number of new cancer cases and deaths, and
oesophageal cancer was the ninth leading cancer in
terms of cases and the sixth in terms of deaths [1]. All
three tumour sites -particularly oesophageal and gastric
cancers- continue to register low survival rates [2-4]. In
Spain, these tumour sites together accounted for 11%
of all cancer-related deaths among men and 8% among
women in 2010 [5].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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rates are higher in men than in women, with this differ-
ence being more pronounced among cancers arising in
the oral cavity, pharynx and oesophagus [6]. They also
share some risk factors, though their relative importance
depends on the type of upper GI cancer. Whereas the
main risk factors for oral cavity and pharyngeal cancer
are alcohol consumption, smoking and human papilloma-
viruses (HPVs), HPV-16 in particular [7,8], the accepted
risk factors for oesophageal cancer include alcohol, smok-
ing, obesity and gastro-oesophageal reflux [9], and those
for gastric cancer are Helicobacter pylori (H. pylori) infec-
tion, diet and smoking [10].
In most European countries, oral cavity and pharyngeal
cancer mortality registered a pronounced increase from
1950 to 1990, a trend that was more marked among men;
indeed, these increases are among the greatest recorded
for any neoplasia [11,12]. Oral cavity and pharyngeal can-
cer mortality also increased in countries such as Canada
and Australia, though to a lesser extent [13]. The trend
has since varied among countries, i.e., while mortality
has declined in most Western European countries, it
has continued to rise in Central and Eastern Europe
[14,15]. Although incidence and mortality trends in oral
and pharyngeal cancer have been classically attributed
to changes in prevalence of exposure to tobacco and al-
cohol (the main risk factors for this group of malignan-
cies), some authors have linked recent increases in the
incidence of these cancers to HPV infection [16].
In the case of oesophageal cancer, incidence and mortal-
ity rates have remained stable in most European Western
countries over the last few decades, albeit with some dif-
ferences [17]. Gastric cancer rates, in contrast, have been
steadily declining for the last 50–60 years [18,19], a fact
that has been associated with increases in the quality of
life in Western countries, including better diet, and the
decline in prevalence of H. pylori infection [10].
This study used age-period-cohort models to analyse
mortality time trends in oral cavity and pharyngeal,
oesophageal and stomach cancers in Spain over the period
1952–2006, and compare similarities and differences in
the birth cohort and period effects.
Methods
Mortality and population data
Population and mortality data for this study are publicly
available from the Spanish National Statistics Institute
(Instituto Nacional de Estadística). During the calendar
period considered (1952–2006), three different Revisions
of the International Classification of Diseases (ICD) were
used. Consequently, the cancer-related deaths studied
respectively corresponded to: ICD-6-7 codes 140 to 148,
ICD-8-9 codes 140 to 149 and ICD-10 codes C00 to C14
for lip, oral cavity and pharyngeal cancer; ICD-6-9 code150 and ICD-10 code C15 for oesophageal cancer; and,
lastly, ICD-6-9 code 151 and ICD-10 code C16 for stom-
ach cancer. The number of deaths due to selected codes
during the study period, broken down by age, gender
and calendar period, were obtained from the Spanish
National Statistics Institute. Spanish population data cor-
responding to censuses and municipal rolls for the mid-
year of each quinquennium were also obtained from the
Spanish National Statistics Institute. Mortality and popu-
lation data were stratified by age group (from 0–4 to
85+ years), sex, calendar period (in eleven 5-year pe-
riods, i.e., 1952–1956, 1957–1961,…, 2002–2006) and
cancer site. Age-adjusted mortality rates (per 100,000
population, standardised to the European Standard
Population) for cancers of the oral cavity and pharynx,
oesophagus and stomach were calculated for each sex
and 5-year calendar period.
Age-period-cohort (APC) models
Separate log-linear Poisson models were fitted to study
the effect of age, period of death and birth cohort for
each sex and tumour site on mortality. Age-specific
mortality rates per 100,000 population for the eleven 5-
year periods considered were used for the APC analysis.
To address the “non-identifiability” problem (i.e., the three
factors -age, period and cohort- are linearly dependent),
we used Osmond and Gardner’s solution [20], as well as
curvature effects and net drift as proposed by Holford
[21]. The Osmond-Gardner solution splits net drift into
cohort and period slopes, by minimising any disagreement
in parameter estimates between the full three-factor
model and each of the two-factor models (age-period,
age-cohort and period-cohort). Then, it is possible to de-
termine two estimable parameters not affected by the
non-identifiability problem: (i) overall change over time
(denominated net drift), which is the sum of the cohort
and period slopes [21]; and (ii) deviation of any period or
cohort estimators from the general trend (denominated
curvature). To display the cohort and period effects
graphically, we used this solution and the respective cur-
vatures. Age groups <30 years, as well as those <20 years
for stomach cancer, were excluded from this analysis due
to the limited number of deaths in these age groups. The
open-ended category of persons aged 85 years and over
was also excluded. We checked for extra-Poisson disper-
sion [22] and, where present, effects were calculated using
a negative binomial distribution.
Curvature change points
The presence of change points in the curvatures of the
cohort and period effects was evaluated by fitting seg-
mented models to the relationship between curvature ef-
fect and time. Details of the recursive algorithm used to
estimate the segmented regression have been published
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using the R package “segmented” [24]. The models pro-
vided: a) the corrected P value of the Davies’ test for the
change point; and 2) the estimate and 95% confidence
interval for the location of the change point.
Results
From 1952 to 2006, there were 71,500 deaths in Spain due
to cancer of the oral cavity and pharynx, 71,997 due to
cancer of oesophagus, and 409,998 due to stomach cancer.
Table 1 and Figure 1 show the trend in adjusted upper
GI cancer mortality rates among men and women. The
following aspects should be noted: 1) the higher frequency
of all three cancers among men, with the respective male–
female ratios for the first and last 5-year periods being 5.0
and 6.0 for oral cavity/pharyngeal cancer, 3.9 and 9.2
for oesophageal cancer, and 1.6 and 2.3 for gastric cancer;
2) the fact that mortality due to oral cavity, pharyngeal
and oesophageal cancers rose among men until 1995 andTable 1 Age-adjusted mortality rates per 100,000 person-yea
in Spanish men and women, for upper gastrointestinal tract
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Total (Deaths) (59,224) (58,822) (23declined thereafter; 3) the increase in oral cavity and
pharyngeal cancer rates, which surpassed those for
oesophageal cancer in 1986 among men and women; 4)
the diverging oesophageal cancer mortality trends in men
and women from the 1970s onwards; and 5) the decline in
stomach cancer mortality in both sexes since 1965.
The specific mortality rates depicted in Figure 2 en-
abled trend patterns linked to age and birth cohort effect
to be identified. For all three tumours and in both sexes
there was an age effect of increasing risk, more markedly
until 55 years of age. The graphs corresponding to oral
cavity, pharyngeal, and oesophageal cancer were very
similar in men and women, and displayed a cohort effect
which increased until generations born in the 1950s and
then subsequently decreased in men, while in women
specific mortality rates increased in the last years of the
study. The graphs corresponding to gastric cancer were
similar between men and women and showed a more
marked decrease among older age groups and in women.rs (European standard population) and number of deaths
cancer mortality, 1952-2006
Women
mach Oral cavity & pharynx Oesophagus Stomach
ate Rate Rate Rate
aths) (Deaths) (Deaths) (Deaths)
1.56 0.78 0.94 25.96
,514) (454) (561) (15,254)
4.36) (0.79) (1.35) (26.46)
,670) (506) (866) (17,144)
7.56) (0.94) (1.68) (27.12)
,878) (662) (1,220) (19,674)
2.77) (0.88) (1.81) (23.88)
,881) (785) (1,462) (19,371)
8.81) (0.90) (1.59) (21.22)
,205) (908) (1,416) (18,984)
1.63) (0.90) (1.39) (16.15)
,995) (948) (1,413) (16,324)
5.03) (0.98) (1.20) (12.44)
,829) (1,092) (1,437) (14,752)
2.34) (1.17) (0.94) (10.66)
,669) (1,418) (1,278) (14,240)
9.46) (1.24) (0.78) (8.77)
,855) (1,661) (1,139) (13,088)
6.60) (1.19) (0.75) (7.20)
,891) (1,756) (1,176) (11,896)
3.78) (1.30) (0.71) (5.95)
,773) (2,086) (1,207) (11,021)
8,250) (12,276) (13,175) (171,748)
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Figure 1 Temporal trends in age-standardised mortality rates per
100,000 person-years (European standard population) for cancers
of the oral cavity and pharynx, oesophagus and stomach in
males (thick lines) and females (thin lines), Spain 1952–2006.
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Figure 3, which depicts the results of the age-period-
cohort models. This figure shows the cohort and period
effects together with their curvatures and change points,
and enables the similarity of the shape of the cohort ef-
fects in the three tumours to be discerned, though the
similarity is greater between oral cavity/pharyngeal and
oesophageal cancers in both sexes. A change point can be
seen, marking a rise in risk among the 1910–1920 cohorts
and a fall in risk among the 1950–1960 cohorts. This lat-
ter pattern was also observable for stomach cancer.
Table 2 shows the deviances of the different models
used. In all cases, the model that provided the best fit to
the data was the age-period-cohort model. The cohort
and period effects were statistically significant for all
three tumour sites studied.
Finally, the trend in the period effect was different for
the three tumours and in line with that described above
for the adjusted rates. Tables 3 and 4 show the change
points detected using segmented regression.Discussion
The results of this study show the time trend in upper
GI tumours in Spain, characterised by: a rise in mortalitydue to oral cavity, pharyngeal and oesophageal cancer
among men until 1995 and its subsequent decline; an in-
crease in oral cavity and pharyngeal cancer rates, which
surpassed those of oesophageal cancer in 1986 for men
and women alike; an increase in recent decades in oral
cavity and pharyngeal cancer among women; diverging
oesophageal cancer mortality trends in men and women
from the 1970s onwards; and a decline in stomach can-
cer mortality in both sexes.
The age-period-cohort analysis reported in this study
shows that for the period effect there is a certain similar-
ity between the sexes in the tumour sites studied, though
there are also some differences. Firstly, there has been
no decline in oral cavity and pharyngeal cancer mortality
risk among women in recent periods. This divergence
between men and women in the trend in oral cavity and
pharyngeal cancer may reflect an increase in smoking
and alcohol consumption among women, an increase in
exposure to HPV, or both.
Secondly, note should be taken of the divergence be-
tween men and women in the oesophageal cancer mor-
tality trend as from 1970. Even though it is accepted the
influence of smoking and alcohol in the aetiology of this
tumour, the incorporation of women to tobacco habit
that occurred in Spain during the last decades of the XX
century is not reflected in the evolution of oesophageal
cancer mortality rates, probably reflecting the lower con-
sumption of alcohol among females [25].
Finally, insofar as the period effect in gastric cancer is
concerned, the effects are similar in both sexes, reflect-
ing a lesser implication of lifestyle habits in this tumour
and a greater role of the exposure to H. pylori in its aeti-
ology. During the last decades, a parallel fall in gastric
cancer mortality rates in Spain in high and low risk areas
and in both sexes has been observed [26], supporting the
possible implication of a constant decrease in H. pylori in-
fection rates and a continuous increase in life-standard
indicators in the trends of gastric cancer incidence and
mortality.
With respect to the cohort effects, attention should be
drawn to the similarity of the results for both sexes in all
three tumour sites, with the resemblance between the
cohort effects in oral cavity/pharyngeal cancer and
oesophageal cancer being especially noteworthy, with 2
waves and coincidence of change points. This similarity
in the shape of the cohort effect across the three tumour
sites suggests exposure to shared risk factors, mainly al-
cohol consumption and smoking, which are risk factors
for oral cavity and pharyngeal cancer, epidermoid carcin-
omas of the oesophagus [27,28] and, to a lesser extent,
gastric cancer [29,30]. Moreover, whereas the change
point in the cohort effect in oral cavity, pharyngeal,
oesophageal and stomach cancers among men was lo-
cated in the 1910, 1920 and 1940 generations
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Figure 2 Age specific mortality rates for cancers of the oral cavity and pharynx, oesophagus and stomach by sex, Spain 1952–2006.
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born around 1920, 1930 and 1940. This correlative
change in the trend in younger generations of womenmight be related to the lag in the increase in the preva-
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Figure 3 Cohort and period effects (thick lines), curvature (thin line) and change points (vertical grey lines) on cancers of the oral
cavity and pharynx, oesophagus and stomach by sex, Spain 1952–2006.
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Table 2 Goodness of fit for age-period-cohort models to upper gastrointestinal tract cancer mortality, Spain 1952-2006
Model Oral cavity & pharynx Oesophagus Stomach
Men D.f. Deviance D.f. Deviance D.f. Deviance
Age 110 7185.8 110 3052.2 130 19676.3
Age + drift 109 3296.2 109 2396.6 129 1923.0
Age + period 100 2145.2 100 1080.9 120 571.4
Age + cohort 90 2404.7 90 2087.0 108 850.4
Age + period + cohort 81 200.6 81 143.0 99 136.8
Annual net-drift* 2.01% 0.72% −2.70%
Women
Age 110 492.8 110 1805.0 130 21345.9
Age + drift 109 312.3 109 860.2 129 2048.3
Age + period 100 287.8 100 319.5 120 1077.6
Age + cohort 90 164.6 90 397.8 108 611.1
Age + period + cohort 81 115.1 81 123.6 99 152.4
Annual net-drift* 1.04% −1.89% −3.50%
D.f. – Degrees of freedom.
*Overall annual percent change in age-adjusted mortality rates obtained from the sum of period and cohort linear slopes from the three-factor model.
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period and cohort effects of upper GI tumours. When it
comes to interpreting the results, it must be borne in
mind that our understanding of the epidemiology of
upper GI tract cancers has changed over recent decades.
With respect to tumours of oral cavity and pharynx, it is
currently accepted that there are two groups of malig-
nant tumours at this site, namely, those associated with
smoking and alcohol consumption, and those associated
with HPV infection [31]. Cases associated with HPV in-
fection have been reported to be younger and have a
better prognosis than HPV-negative cases [32,33]. The
decrease in exposure to smoking and alcohol, along with
changes in legislation, has resulted in a decline in the in-
cidence and mortality rates of associated SCCs. At the
same time as this has been occurring, however, there hasTable 3 Cohort effect points of change on upper gastrointest
Tumour Birth year
(95% CI)
Oral cavity & pharynx
Men 1910.9 (1908.4 - 1913.4)
Women 1921.3 (1916.3 - 1926.4)
Oesophagus
Men 1919.2 (1915.3 - 1923.2)
Women 1897.3 (1888.5 - 1906.2)
Stomach
Men 1889.0 (1886.1 - 1891.9)
Women 1889.5 (1884.7 - 1894.3)
† Year of birth with significant trend change as obtained from the segmented regrebeen an increase in incidence and mortality in respect of
some cancer sites included in the oral cavity and
pharyngeal cancer group, due to HPV infection [31]. In
Sweden, for instance, a highly significant and parallel in-
crease has been reported in both the incidence of tonsillar
and base-of-tongue SCC cancers and the proportion of
HPV-positive tumours [34,35]. Furthermore, on studying
the trend in HPV-positive tonsillar SCC in the County of
Stockholm, Nasman et al. found a doubling of HPV-
positive cases between 1970 and 2007, accompanied by a
parallel decrease in the proportion of HPV-negative tu-
mours [36].
The evidence of a role for HPV in the pathogenesis of
oral cavity and pharyngeal cancers is thus both molecu-
lar and epidemiological. If the increase in the proportion
of HPV-related cases had occurred among youngerinal tract cancer mortality by sex, Spain 1952–2006
Changes in cohort effect†
Birth year Birth year
(95% CI) (95% CI)
1956.8 (1955.1 - 1958.5)
1964.2 (1962.5 – 1966.0)
1950.8 (1947.9 - 1953.6)
1929.9 (1922.8 - 1937.0) 1959.3 (1956.2 - 1962.3)
1940.0 (1931.9 – 1948.0) 1954.9 (1950.5 - 1959.4)
1938.6 (1932.2 - 1945.0) 1956.5 (1946.5 - 1966.6)
ssion analysis of cohort curvatures from the three-factor model.
Table 4 Period effect points of change on upper
gastrointestinal tract cancer mortality by sex, Spain
1952–2006
Tumour
Changes in period effect†
Year of death Year of death
(95% CI) (95% CI)
Oral cavity & pharynx
Men 1974.2 (1968.9 - 1979.5) 1994.6 (1990.3 - 1998.9)
Women 1972.7 (1963.2 - 1982.3)
Oesophagus
Men 1972.7 (1969.8 - 1975.5) 1991.6 (1987.5 - 1995.6)
Women 1966.8 (1965.6 - 1967.9) 1994.1 (1985.8 - 2002.4)
Stomach
Men 1965.2 (1963.1 - 1967.4)
Women 1966.2 (1963.6 - 1968.8)
† Year of death with significant trend change as obtained from the segmented
regression analysis of period curvatures from the three-factor model.
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thus account for the second wave of the cohort effect
and the subsequent decline in men and women alike.
Moreover, if the increase in oropharyngeal cancer mor-
tality in women were found to coincide with an increase
in survival, one could speculate that the rise in incidence
should be even higher.
HPV, one of the most frequent sexually transmitted in-
fections world-wide [37], is a recognised risk factor for
oral cavity and oropharyngeal cancer [38,39]. Although
the association between HPV and different cancers is ac-
cepted, the epidemiology and natural history of human
papillomavirus infection is not yet well understood [40].
Over 100 HPV types have been described, some being
highly oncogenic, with a role in the aetiology of anogenital
(mainly cervical) [38,41] and oropharyngeal neoplasms
[8]. Both genital and oral HPV infection are predomin-
antly sexually transmitted [42]. With regard to oral HPV
infection, though infection resolves over time in most
cases, HPV infection persists in a small percentage of indi-
viduals; and, while it is not known which factors may
affect the persistence of the infection, both pathogen and
host factors, as well as some environmental co-factors,
may possibly be implicated [40].
Regarding knowledge of the prevalence of HPV infec-
tion in the general population, a broad range of esti-
mates can be found, depending on study characteristics,
geographical area, calendar period, age group, testing
technology, etc., since HPV prevalence depends on the
cultural, sexual and lifestyle habits of the populations,
which also vary over time. World-wide prevalence of
genital HPV infection in women with normal cytological
findings has been estimated to be around 11.7% [43].
With regard to oral HPV infection, a global prevalence
of 4.5% was reported for the general adult populationworld-wide [44], though this estimate was greater in de-
veloping (7.3%) than in developed nations (3.6%). A re-
cent study in the United States reported an overall
prevalence of oral HPV infection of 6.9% among men
and women aged 14–69 years, with men having a higher
prevalence than women (10.1% vs. 3.6%). While the
prevalence of genital HPV infection in Spain has been
reported to be among the lowest in Europe [45,46],
changes in sexual lifestyles in young Spanish cohorts,
with higher risk of HPV infection, have nevertheless
been reported [47].
Since a clear association between HPV and oropha-
ryngeal SCC has been accepted, the histological similar-
ities between the oral squamous epithelium and upper
oesophagus would suggest a similar association [48].
Yet, even though studies that have assessed the role of
HPV in oesophageal SCC have, as in the case of oral
cavity and pharyngeal cancers, found virus in samples
of tumour tissue, the evidence accumulated to date
does not allow for a similar association to be inferred
[39]. In Spain, whereas incidence of oesophageal SCC
in males rose from 1980 until 1986 and then began to
decline, among females it increased from 1980–1994
and remained stable from 1994–2003 [49], describing a
trend that is more like that of oral cavity and pharyngeal
cancer mortality than that of oesophageal cancer as a
whole. There may possibly be other types of HPV impli-
cated in oesophageal cancer [50], in much the same
way as HPV6 has been associated with laryngeal cancer
[39]. Further studies are thus needed to understand the
natural history of the virus and its role in oesophageal
carcinogenesis.
One specific aspect of the gastric cancer mortality
time trend is the change point observed in the cohort ef-
fect in generations born from 1940 to 1955, which
would correspond to the aftermath of the Spanish Civil
War (1936–1939) and would highlight the importance of
exposure to risk factors at early ages of life. H. pylori in-
fection rates have been reported to be higher during
childhood, and they are inversely associated with hygiene
practices [51]. In many European Union countries small
shifts in the downward trend in gastric cancer mortality
have similarly been observed in generations born around
the 1940s, which could also be related to worse living
conditions in the first years of life among generations
born during and immediately after the Second World
War [18].
One aspect that also characterises the epidemiology of
the three tumour sites studied are the higher incidence
and mortality rates among men than among women,
with this difference being smaller for gastric cancer [6].
On comparing the last to the first five-year period stud-
ied, a rise will be seen in the male–female ratio, particu-
larly in the case of oesophageal cancer. This difference
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tributable risk of oral cavity, pharyngeal and oesophageal
cancer for smoking and alcohol consumption among
men than among women [27,28], though other hypoth-
eses could be considered. Marur et al. [31] suggested
that higher HPV prevalence in cervical as opposed to
penile tissue might boost the chances of HPV infection
in men when performing oral sex, and so contribute to
the higher rate of HPV-related oropharyngeal cancer in
men.
In order to show the results of the age-period-cohort
models, we opted for Osmond and Gardner’s solution,
as well as the evaluation of estimable parameters pro-
posed by Holford. The existence of different solutions is
a source of uncertainty, since all of them are subject to
limitations and it is difficult to ascertain which is the
most appropriate. Even so, there are many components
of the information depicted graphically that do not vary
across the different solutions, e.g., the shape of the co-
hort effect (local changes or curvature) is independent
of the solution chosen. Hence, where a trend is observed
in the cohort effect, generally speaking this remains
relatively unchanged in the different solutions. The
graph-based representation of the cohort effect makes
it possible to detect the generation marking the shift in
trend. The same applies to period effects -change or in-
flection points in the trend- which remain visible
throughout.
When it comes to interpreting the extreme values of
the cohort effects (the oldest and youngest cohorts) in
this type of analysis, one must bear in mind that these
are estimated with a single cell of the rates matrix and
so are extremely unstable. This is especially so in the
case of the extreme values of the youngest cohort, since
these are calculated on the basis of very few cases. Con-
sequently, any sharp changes at the extremes of the co-
hort effects must be interpreted with great caution,
particularly those limited to the latest birth cohorts (e.g.,
the youngest cohorts in women).
One strength of this study is that it involves the
follow-up of the total Spanish population across 55 years.
This is thus a dynamic cohort, with entries and exits
across the study period, which encompasses generations
born approximately from 1865 to 1985 and thus consti-
tutes an important time series. At the same time, the
fact that its spans such a long time period means that
some of the results might be due to changes in the qual-
ity of death registration, in the coding of causes of death,
and/or in survival. At all events, mortality data are the
only data that enable such a long series to be studied in
the Spanish population as a whole, and the quality of
such data for the case of cancer has not only been dem-
onstrated, but has also been shown to be similar to that
of other countries in the region [52].Furthermore, the low survival rate means that mortal-
ity due to the causes studied is a good approximation of
incidence. In the period 1995–1999, relative age-
adjusted survival at 5 years in Spain was 9.7% for
oesophageal cancer and 27.8% for stomach cancer. For
oral cavity and pharyngeal cancer, survival was higher
(36.5% in men and 53.1% in women) [2,3], which could
explain the change in the oral cavity and pharyngeal age
adjusted mortality rates trend among men and women
from 1995 onwards.Conclusion
In conclusion, the similarities displayed by the trends in
the tumours studied -especially those of the oral cavity,
pharynx and oesophagus- would support the implication
of shared risk factors. Many of the risk factors described
are preventable factors, such as smoking and alcohol
consumption. Furthermore, HPV vaccination was ap-
proved in Spain in 2007 for the prevention of cervical
cancer [53]. Though the protective role of HPV vaccin-
ation against nongenital cancers is still under study, it
might have an effect on the prevention of all HPV-
associated malignancies. However, such HPV vaccination
programmes target women. In future, monitoring should
focus on trends in non-cervical HPV-related neoplasms,
in both men and women, particularly at cancer sites with
rising incidence rates. From a health-promotion stand-
point, it might also be advisable to educate the general
population about HPV transmission routes and the role
of HPV in the aetiology of oral cavity and pharyngeal
cancer, as well as dentists and physicians who diagnose
and treat head and neck cancers, since effective screen-
ing modalities are limited in some of these sites.
Our results highlight the importance of continuing to
study the causes implicated in the aetiology of these tu-
mours, as well as the need to insist on primary prevention
measures targeting known risk factors and secondary pre-
vention measures.
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